iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by SFE Investment Counsel

SFE Investment Counsel cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 5.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,658 shares of the financial services provider’s stock after selling 145 shares during the quarter. SFE Investment Counsel’s holdings in iShares Biotechnology ETF were worth $361,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Moneta Group Investment Advisors LLC lifted its holdings in iShares Biotechnology ETF by 131,598.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock valued at $586,846,000 after acquiring an additional 4,466,451 shares during the period. JPMorgan Chase & Co. raised its stake in shares of iShares Biotechnology ETF by 159.9% during the 1st quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock worth $253,975,000 after buying an additional 1,209,700 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of iShares Biotechnology ETF by 49.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after buying an additional 521,820 shares during the period. Jane Street Group LLC raised its stake in shares of iShares Biotechnology ETF by 5.4% during the 4th quarter. Jane Street Group LLC now owns 1,002,554 shares of the financial services provider’s stock worth $131,625,000 after buying an additional 50,999 shares during the period. Finally, International Assets Investment Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $76,425,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.1 %

Shares of IBB stock opened at $124.46 on Friday. The stock has a 50 day simple moving average of $135.29 and a 200-day simple moving average of $129.51. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.